Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Irvine › NPI 1346467354
Lab

International Medical Laboratory

International Medical Laboratory was paid $726K by Medicaid between Jan 2018 and Oct 2024, across 121 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 28% of everything it billed.

33Billing provider infoINTERNATIONAL MEDICAL LABORATORY
IRVINE, CA 92606
33aNPI1346467354assigned 04/19/2007
33bProvider typeClinical Medical Laboratory
28Total paid$726K
24GClaims90,328
24DCodes billed121
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#210 of 561
Median peer was paid$222K
This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201817,436$104K
20194,270$64K
20201,416$6K
20212,404$16K
20223,034$36K
202312,835$135K
2024incomplete48,933$365K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 28% 1,908 1,779 $202K
88312 7.7% 1,518 1,511 $56K
88305 Level IV - Surgical pathology, gross and microscopic examination 7.1% 2,061 2,045 $52K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.2% 694 198 $37K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 3.5% 311 263 $26K
87481 2.9% 1,422 1,387 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.6% 765 743 $19K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.5% 765 740 $18K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2.5% 1,101 1,084 $18K
87653 2.2% 1,314 1,284 $16K
87806 2.1% 727 624 $16K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.1% 1,357 1,329 $16K
109 more codes
87640 2.1% 1,149 $15K
84443 Thyroid stimulating hormone (TSH) 2.1% 3,517 $15K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 5,882 $14K
80053 Comprehensive metabolic panel 1.9% 5,073 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.8% 2,665 $13K
83021 1.7% 3,201 $12K
80061 Lipid panel 1.6% 3,681 $12K
87631 1.3% 529 $10K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.3% 126 $9K
88313 1.1% 260 $8K
86780 <1% 741 $7K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 1,917 $7K
87486 <1% 628 $6K
87541 <1% 630 $6K
87581 <1% 630 $6K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 48 $6K
88142 <1% 412 $5K
88311 <1% 1,148 $5K
84439 <1% 1,926 $3K
84481 <1% 1,467 $3K
87340 <1% 479 $2K
86803 <1% 407 $2K
84432 <1% 1,073 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 113 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 142 $2K
87077 <1% 606 $2K
86376 <1% 1,206 $2K
82747 <1% 311 $2K
81000 <1% 2,359 $2K
82607 <1% 1,594 $2K
87500 <1% 398 $2K
87641 <1% 390 $2K
86762 <1% 125 $1K
82746 <1% 1,416 $1K
87081 <1% 370 $1K
84550 <1% 2,217 $1K
84153 <1% 618 $1K
82728 <1% 1,242 $1K
83880 <1% 599 $1K
36415 Collection of venous blood by venipuncture <1% 2,528 $1K
83615 <1% 799 $828.21
84702 <1% 66 $757.23
86039 <1% 1,034 $693.11
83550 <1% 1,281 $685.86
87625 <1% 54 $661.74
86329 <1% 987 $643.02
83540 <1% 1,401 $639.26
82652 <1% 173 $628.55
87086 Culture, bacterial; quantitative colony count, urine <1% 471 $578.10
86800 <1% 490 $571.98
84480 <1% 199 $553.45
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 16 $533.76
86431 <1% 1,158 $530.92
82172 <1% 689 $512.47
83010 <1% 957 $496.76
88141 <1% 96 $434.72
84134 <1% 109 $413.52
84436 <1% 452 $381.58
87210 <1% 226 $378.93
84403 <1% 270 $372.92
83735 <1% 652 $366.54
83520 <1% 573 $352.96
82977 <1% 236 $346.08
84100 <1% 839 $341.69
86140 <1% 867 $340.26
86704 <1% 110 $334.69
86060 <1% 709 $333.61
86706 <1% 119 $322.35
86708 <1% 103 $306.21
86850 <1% 95 $275.40
85651 <1% 1,391 $271.83
84479 <1% 312 $260.64
87088 <1% 266 $259.59
86141 <1% 456 $256.38
86694 <1% 16 $249.84
86200 <1% 558 $214.07
87184 <1% 167 $197.50
84154 <1% 205 $196.41
85730 <1% 144 $193.65
83090 <1% 278 $185.91
86705 <1% 80 $185.09
85610 <1% 175 $174.20
80069 <1% 95 $168.09
83721 <1% 389 $151.72
86900 <1% 69 $148.81
85044 <1% 957 $138.93
86901 <1% 57 $126.67
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 84 $125.00
82043 <1% 278 $111.97
86709 <1% 61 $102.26
82570 <1% 288 $81.43
82785 <1% 80 $74.82
80164 <1% 12 $71.50
84402 <1% 58 $70.01
87252 <1% 13 $61.53
80048 Basic metabolic panel (calcium, ionized) <1% 14 $60.32
84270 <1% 58 $58.55
87529 <1% 13 $58.08
82550 <1% 305 $55.53
82784 <1% 89 $52.39
82787 <1% 77 $28.63
82670 <1% 13 $24.71
85384 <1% 85 $19.06
84482 <1% 91 $15.44
83690 <1% 28 $12.83
86038 <1% 17 $10.52
82465 0% 13 $0.00
84166 0% 27 $0.00
84478 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZARGHAMI, JALAL (PRESIDENT)